サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1123434

世界の肺疾患向け薬物送達システム市場：考察と予測 (2028年まで)

Global Pulmonary Drug Delivery Systems Market Insights and Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 129 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の肺疾患向け薬物送達システム市場：考察と予測 (2028年まで)
出版日: 2022年09月08日
発行: QYResearch
ページ情報: 英文 129 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、肺疾患向け薬物送達システム (Pulmonary Drug Delivery Systems) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 肺疾患向け薬物送達システムの製品概要
  • 市場：タイプ別
    • 世界の肺疾患向け薬物送達システムの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Nebulizers
    • Dry Powder Inhaler (DPI)
    • Metered Dose Inhaler (MDI)
  • 市場：アプリケーション別
    • 世界の肺疾患向け薬物送達システムの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • COPD
    • Asthma
    • Others
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の肺疾患向け薬物送達システムの販売 推定および予測 2017-2028
  • 世界の肺疾患向け薬物送達システムの収益 推定および予測 2017-2028
  • 世界の肺疾患向け薬物送達システムの収益：地域別: 2017 VS 2021 VS 2028
  • 世界の肺疾患向け薬物送達システムの販売：地域別
    • 世界の肺疾患向け薬物送達システムの販売：地域別 (2017-2022)
    • 世界の販売 肺疾患向け薬物送達システム ：地域別 (2023-2028)
  • 世界の肺疾患向け薬物送達システムの収益：地域別
    • 世界の肺疾患向け薬物送達システムの収益：地域別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の肺疾患向け薬物送達システムの販売：メーカー別
    • 世界の肺疾患向け薬物送達システムの上位メーカー：販売別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 肺疾患向け薬物送達システム2021
  • 世界の肺疾患向け薬物送達システムの収益：メーカー別
    • 世界の肺疾患向け薬物送達システムの収益：メーカー別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 肺疾患向け薬物送達システムの収益 2021
  • 世界の肺疾患向け薬物送達システムの販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の肺疾患向け薬物送達システムの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の肺疾患向け薬物送達システムのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の肺疾患向け薬物送達システムの販売：タイプ別
    • 世界の肺疾患向け薬物送達システムの販売実績：タイプ別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの販売予測：タイプ別 (2023-2028)
    • 世界の肺疾患向け薬物送達システムの販売市場シェア：タイプ別 (2017-2028)
  • 世界の肺疾患向け薬物送達システムの収益：タイプ別
    • 世界の肺疾患向け薬物送達システムの収益実績：タイプ別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの収益予測：タイプ別 (2023-2028)
    • 世界の肺疾患向け薬物送達システムの収益市場シェア：タイプ別 (2017-2028)
  • 世界の肺疾患向け薬物送達システムの価格：タイプ別
    • 世界の肺疾患向け薬物送達システムの価格：タイプ別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界の肺疾患向け薬物送達システムの販売：アプリケーション別
    • 世界の肺疾患向け薬物送達システムの販売実績：アプリケーション別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの販売予測：アプリケーション別 (2023-2028)
    • 世界の肺疾患向け薬物送達システムの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の肺疾患向け薬物送達システムの収益：アプリケーション別
    • 世界の肺疾患向け薬物送達システムの収益実績：アプリケーション別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの収益予測：アプリケーション別 (2023-2028)
    • 世界の肺疾患向け薬物送達システムの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の肺疾患向け薬物送達システムの価格：アプリケーション別
    • 世界の肺疾患向け薬物送達システムの価格：アプリケーション別 (2017-2022)
    • 世界の肺疾患向け薬物送達システムの価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の肺疾患向け薬物送達システム 市場規模：タイプ別
    • 北米の肺疾患向け薬物送達システムの販売：タイプ別 (2017-2028)
    • 北米の肺疾患向け薬物送達システムの収益：タイプ別 (2017-2028)
  • 北米の肺疾患向け薬物送達システム 市場規模：アプリケーション別
    • 北米の肺疾患向け薬物送達システムの販売：アプリケーション別 (2017-2028)
    • 北米の肺疾患向け薬物送達システムの収益：アプリケーション別 (2017-2028)
  • 北米の肺疾患向け薬物送達システム 市場規模：国別
    • 北米の肺疾患向け薬物送達システムの販売：国別 (2017-2028)
    • 北米の肺疾患向け薬物送達システムの収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の肺疾患向け薬物送達システム 市場規模：タイプ別
    • 欧州の肺疾患向け薬物送達システムの販売：タイプ別 (2017-2028)
    • 欧州の肺疾患向け薬物送達システムの収益：タイプ別 (2017-2028)
  • 欧州の肺疾患向け薬物送達システム 市場規模：アプリケーション別
    • 欧州の肺疾患向け薬物送達システムの販売：アプリケーション別 (2017-2028)
    • 欧州の肺疾患向け薬物送達システムの収益：アプリケーション別 (2017-2028)
  • 欧州の肺疾患向け薬物送達システム 市場規模：国別
    • 欧州の肺疾患向け薬物送達システムの販売：国別 (2017-2028)
    • 欧州の肺疾患向け薬物送達システムの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の肺疾患向け薬物送達システム 市場規模：タイプ別
    • アジア太平洋の肺疾患向け薬物送達システムの販売：タイプ別 (2017-2028)
    • アジア太平洋の肺疾患向け薬物送達システムの収益：タイプ別 (2017-2028)
  • アジア太平洋の肺疾患向け薬物送達システム 市場規模：アプリケーション別
    • アジア太平洋の肺疾患向け薬物送達システムの販売：アプリケーション別 (2017-2028)
    • アジア太平洋の肺疾患向け薬物送達システムの収益：アプリケーション別 (2017-2028)
  • アジア太平洋の肺疾患向け薬物送達システム 市場規模：地域別
    • アジア太平洋の肺疾患向け薬物送達システムの販売：地域別 (2017-2028)
    • アジア太平洋の肺疾患向け薬物送達システムの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカの肺疾患向け薬物送達システム 市場規模：タイプ別
    • ラテンアメリカの肺疾患向け薬物送達システムの販売：タイプ別 (2017-2028)
    • ラテンアメリカの肺疾患向け薬物送達システムの収益：タイプ別 (2017-2028)
  • ラテンアメリカの肺疾患向け薬物送達システム 市場規模：アプリケーション別
    • ラテンアメリカの肺疾患向け薬物送達システムの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの肺疾患向け薬物送達システムの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの肺疾患向け薬物送達システム 市場規模：国別
    • ラテンアメリカの肺疾患向け薬物送達システムの販売：国別 (2017-2028)
    • ラテンアメリカの肺疾患向け薬物送達システムの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの肺疾患向け薬物送達システム 市場規模：タイプ別
    • 中東・アフリカの肺疾患向け薬物送達システムの販売：タイプ別 (2017-2028)
    • 中東・アフリカの肺疾患向け薬物送達システムの収益：タイプ別 (2017-2028)
  • 中東・アフリカの肺疾患向け薬物送達システム 市場規模：アプリケーション別
    • 中東・アフリカの肺疾患向け薬物送達システムの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの肺疾患向け薬物送達システムの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの肺疾患向け薬物送達システム 市場規模：国別
    • 中東・アフリカの肺疾患向け薬物送達システムの販売：国別 (2017-2028)
    • 中東・アフリカの肺疾患向け薬物送達システムの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • 3M
  • GSK
  • AstraZeneca
  • Cipla
  • Chiesi
  • Boehringer Ingelheim
  • Aptar
  • Novartis
  • Philips Respironics
  • Omron Healthcare
  • PARI
  • Skyepharma
  • CareFusion
  • Shanghai Huarui
  • Taian Character
  • Chia Tai Tianqing

第12章 業界チェーンと販売チャネルの分析

  • 肺疾患向け薬物送達システム 業界チェーン分析
  • 肺疾患向け薬物送達システム 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 肺疾患向け薬物送達システム 生産形態とプロセス
  • 肺疾患向け薬物送達システム 販売およびマーケティング
    • 肺疾患向け薬物送達システム 販売チャネル
    • 肺疾患向け薬物送達システム 卸業者
  • 肺疾患向け薬物送達システム 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 肺疾患向け薬物送達システム 業界動向
  • 肺疾患向け薬物送達システム 市場の促進要因
  • 肺疾患向け薬物送達システム 市場の課題
  • 肺疾患向け薬物送達システム 市場の抑制要因

第14章 世界の肺疾患向け薬物送達システムの主な市場調査結果

第15章 付録

図表
  • Table 1. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Nebulizers
  • Table 3. Major Manufacturers of Dry Powder Inhaler (DPI)
  • Table 4. Major Manufacturers of Metered Dose Inhaler (MDI)
  • Table 5. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Pulmonary Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Pulmonary Drug Delivery Systems Sales by Region (2017-2022) & (M Units)
  • Table 8. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
  • Table 9. Global Pulmonary Drug Delivery Systems Sales by Region (2023-2028) & (M Units)
  • Table 10. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2023-2028)
  • Table 11. Global Pulmonary Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2017-2022)
  • Table 13. Global Pulmonary Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2023-2028)
  • Table 15. Global Pulmonary Drug Delivery Systems Sales by Manufacturers (2017-2022) & (M Units)
  • Table 16. Global Pulmonary Drug Delivery Systems Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Pulmonary Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
  • Table 19. Pulmonary Drug Delivery Systems Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 20. Global Pulmonary Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Pulmonary Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Systems as of 2021)
  • Table 22. Pulmonary Drug Delivery Systems Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Pulmonary Drug Delivery Systems Product Offered
  • Table 24. Date of Manufacturers Enter into Pulmonary Drug Delivery Systems Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 27. Global Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 28. Global Pulmonary Drug Delivery Systems Sales Share by Type (2017-2022)
  • Table 29. Global Pulmonary Drug Delivery Systems Sales Share by Type (2023-2028)
  • Table 30. Global Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2017-2022)
  • Table 33. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2023-2028)
  • Table 34. Pulmonary Drug Delivery Systems Price by Type (2017-2022) & (US$/Unit)
  • Table 35. Global Pulmonary Drug Delivery Systems Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 36. Global Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 37. Global Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 38. Global Pulmonary Drug Delivery Systems Sales Share by Application (2017-2022)
  • Table 39. Global Pulmonary Drug Delivery Systems Sales Share by Application (2023-2028)
  • Table 40. Global Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2017-2022)
  • Table 43. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2023-2028)
  • Table 44. Pulmonary Drug Delivery Systems Price by Application (2017-2022) & (US$/Unit)
  • Table 45. Global Pulmonary Drug Delivery Systems Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 46. North America Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 47. North America Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 48. North America Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 51. North America Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 52. North America Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
  • Table 55. North America Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
  • Table 56. North America Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 59. Europe Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 60. Europe Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 63. Europe Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 64. Europe Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
  • Table 67. Europe Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
  • Table 68. Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 71. Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 72. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 75. Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 76. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2017-2022) & (M Units)
  • Table 79. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2023-2028) & (M Units)
  • Table 80. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 83. Latin America Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 84. Latin America Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 87. Latin America Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 88. Latin America Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
  • Table 91. Latin America Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
  • Table 92. Latin America Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
  • Table 95. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
  • Table 96. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
  • Table 99. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
  • Table 100. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
  • Table 103. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
  • Table 104. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. 3M Corporation Information
  • Table 107. 3M Description and Major Businesses
  • Table 108. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 109. 3M Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. 3M Recent Developments
  • Table 111. GSK Corporation Information
  • Table 112. GSK Description and Major Businesses
  • Table 113. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 114. GSK Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. GSK Recent Developments
  • Table 116. AstraZeneca Corporation Information
  • Table 117. AstraZeneca Description and Major Businesses
  • Table 118. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 119. AstraZeneca Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. AstraZeneca Recent Developments
  • Table 121. Cipla Corporation Information
  • Table 122. Cipla Description and Major Businesses
  • Table 123. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 124. Cipla Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Cipla Recent Developments
  • Table 126. Chiesi Corporation Information
  • Table 127. Chiesi Description and Major Businesses
  • Table 128. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 129. Chiesi Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Chiesi Recent Developments
  • Table 131. Boehringer Ingelheim Corporation Information
  • Table 132. Boehringer Ingelheim Description and Major Businesses
  • Table 133. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 134. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Boehringer Ingelheim Recent Developments
  • Table 136. Aptar Corporation Information
  • Table 137. Aptar Description and Major Businesses
  • Table 138. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 139. Aptar Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Aptar Recent Developments
  • Table 141. Novartis Corporation Information
  • Table 142. Novartis Description and Major Businesses
  • Table 143. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 144. Novartis Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Novartis Recent Developments
  • Table 146. Philips Respironics Corporation Information
  • Table 147. Philips Respironics Description and Major Businesses
  • Table 148. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 149. Philips Respironics Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Philips Respironics Recent Developments
  • Table 151. Omron Healthcare Corporation Information
  • Table 152. Omron Healthcare Description and Major Businesses
  • Table 153. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 154. Omron Healthcare Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Omron Healthcare Recent Developments
  • Table 156. PARI Corporation Information
  • Table 157. PARI Description and Major Businesses
  • Table 158. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 159. PARI Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. PARI Recent Developments
  • Table 161. Skyepharma Corporation Information
  • Table 162. Skyepharma Description and Major Businesses
  • Table 163. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 164. Skyepharma Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Skyepharma Recent Developments
  • Table 166. CareFusion Corporation Information
  • Table 167. CareFusion Description and Major Businesses
  • Table 168. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 169. CareFusion Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 170. CareFusion Recent Developments
  • Table 171. Shanghai Huarui Corporation Information
  • Table 172. Shanghai Huarui Description and Major Businesses
  • Table 173. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 174. Shanghai Huarui Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 175. Shanghai Huarui Recent Developments
  • Table 176. Taian Character Corporation Information
  • Table 177. Taian Character Description and Major Businesses
  • Table 178. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 179. Taian Character Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 180. Taian Character Recent Developments
  • Table 181. Chia Tai Tianqing Corporation Information
  • Table 182. Chia Tai Tianqing Description and Major Businesses
  • Table 183. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 184. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 185. Chia Tai Tianqing Recent Developments
  • Table 186. Key Raw Materials Lists
  • Table 187. Raw Materials Key Suppliers Lists
  • Table 188. Pulmonary Drug Delivery Systems Distributors List
  • Table 189. Pulmonary Drug Delivery Systems Customers List
  • Table 190. Pulmonary Drug Delivery Systems Market Trends
  • Table 191. Pulmonary Drug Delivery Systems Market Drivers
  • Table 192. Pulmonary Drug Delivery Systems Market Challenges
  • Table 193. Pulmonary Drug Delivery Systems Market Restraints
  • Table 194. Research Programs/Design for This Report
  • Table 195. Key Data Information from Secondary Sources
  • Table 196. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pulmonary Drug Delivery Systems Product Picture
  • Figure 3. Global Pulmonary Drug Delivery Systems Market Share by Type in 2021 & 2028
  • Figure 3. Nebulizers Product Picture
  • Figure 4. Dry Powder Inhaler (DPI) Product Picture
  • Figure 5. Metered Dose Inhaler (MDI) Product Picture
  • Figure 6. Global Pulmonary Drug Delivery Systems Market Share by Application in 2021 & 2028
  • Figure 7. COPD
  • Figure 8. Asthma
  • Figure 9. Others
  • Figure 10. Pulmonary Drug Delivery Systems Report Years Considered
  • Figure 11. Global Pulmonary Drug Delivery Systems Sales 2017-2028 (M Units)
  • Figure 12. Global Pulmonary Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Pulmonary Drug Delivery Systems Revenue 2017-2028 (US$ Million)
  • Figure 14. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 15. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
  • Figure 16. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2023-2028)
  • Figure 17. North America Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
  • Figure 18. North America Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Europe Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
  • Figure 20. Europe Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Asia-Pacific Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
  • Figure 22. Asia-Pacific Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Latin America Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
  • Figure 24. Latin America Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Middle East & Africa Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
  • Figure 26. Middle East & Africa Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. The Pulmonary Drug Delivery Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Pulmonary Drug Delivery Systems in the World: Market Share by Pulmonary Drug Delivery Systems Revenue in 2021
  • Figure 29. Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 30. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 31. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 32. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 33. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 34. North America Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 35. North America Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 36. North America Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 37. North America Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 38. North America Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
  • Figure 39. North America Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
  • Figure 40. U.S. Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 41. Canada Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 42. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 43. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 44. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 45. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 46. Europe Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
  • Figure 47. Europe Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
  • Figure 48. Germany Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 49. France Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 50. U.K. Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 51. Italy Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 52. Russia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 53. Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Pulmonary Drug Delivery Systems Sales Share by Region (2017-2028)
  • Figure 58. Asia Pacific Pulmonary Drug Delivery Systems Revenue Share by Region (2017-2028)
  • Figure 59. China Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 60. Japan Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 61. South Korea Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 62. India Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 63. Australia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 64. China Taiwan Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 65. Indonesia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 66. Thailand Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 67. Malaysia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
  • Figure 73. Latin America Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 85. UAE Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
  • Figure 86. Pulmonary Drug Delivery Systems Value Chain
  • Figure 87. Pulmonary Drug Delivery Systems Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed
目次

This research report focuses on the Pulmonary Drug Delivery Systems Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Pulmonary Drug Delivery Systems Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Nebulizers
    • 1.2.3 Dry Powder Inhaler (DPI)
    • 1.2.4 Metered Dose Inhaler (MDI)
  • 1.3 Market by Application
    • 1.3.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 COPD
    • 1.3.3 Asthma
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Pulmonary Drug Delivery Systems Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Pulmonary Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Pulmonary Drug Delivery Systems Sales by Region
    • 2.4.1 Global Pulmonary Drug Delivery Systems Sales by Region (2017-2022)
    • 2.4.2 Global Sales Pulmonary Drug Delivery Systems by Region (2023-2028)
  • 2.5 Global Pulmonary Drug Delivery Systems Revenue by Region
    • 2.5.1 Global Pulmonary Drug Delivery Systems Revenue by Region (2017-2022)
    • 2.5.2 Global Pulmonary Drug Delivery Systems Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Pulmonary Drug Delivery Systems Sales by Manufacturers
    • 3.1.1 Global Top Pulmonary Drug Delivery Systems Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Systems in 2021
  • 3.2 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers
    • 3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Systems Revenue in 2021
  • 3.3 Global Pulmonary Drug Delivery Systems Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Pulmonary Drug Delivery Systems Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Pulmonary Drug Delivery Systems Sales by Type
    • 4.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Type (2017-2022)
    • 4.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
  • 4.2 Global Pulmonary Drug Delivery Systems Revenue by Type
    • 4.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
  • 4.3 Global Pulmonary Drug Delivery Systems Price by Type
    • 4.3.1 Global Pulmonary Drug Delivery Systems Price by Type (2017-2022)
    • 4.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Pulmonary Drug Delivery Systems Sales by Application
    • 5.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Application (2017-2022)
    • 5.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
  • 5.2 Global Pulmonary Drug Delivery Systems Revenue by Application
    • 5.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
  • 5.3 Global Pulmonary Drug Delivery Systems Price by Application
    • 5.3.1 Global Pulmonary Drug Delivery Systems Price by Application (2017-2022)
    • 5.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Pulmonary Drug Delivery Systems Market Size by Type
    • 6.1.1 North America Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
    • 6.1.2 North America Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
  • 6.2 North America Pulmonary Drug Delivery Systems Market Size by Application
    • 6.2.1 North America Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
    • 6.2.2 North America Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
  • 6.3 North America Pulmonary Drug Delivery Systems Market Size by Country
    • 6.3.1 North America Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
    • 6.3.2 North America Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Pulmonary Drug Delivery Systems Market Size by Type
    • 7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
    • 7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
  • 7.2 Europe Pulmonary Drug Delivery Systems Market Size by Application
    • 7.2.1 Europe Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
    • 7.2.2 Europe Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
  • 7.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
    • 7.3.1 Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
    • 7.3.2 Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Type
    • 8.1.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Application
    • 8.2.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Region
    • 8.3.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Pulmonary Drug Delivery Systems Market Size by Type
    • 9.1.1 Latin America Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
    • 9.1.2 Latin America Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
  • 9.2 Latin America Pulmonary Drug Delivery Systems Market Size by Application
    • 9.2.1 Latin America Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
    • 9.2.2 Latin America Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
  • 9.3 Latin America Pulmonary Drug Delivery Systems Market Size by Country
    • 9.3.1 Latin America Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
    • 9.3.2 Latin America Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Type
    • 10.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Application
    • 10.2.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Country
    • 10.3.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 3M
    • 11.1.1 3M Corporation Information
    • 11.1.2 3M Overview
    • 11.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 3M Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 3M Recent Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 GSK Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GSK Recent Developments
  • 11.3 AstraZeneca
    • 11.3.1 AstraZeneca Corporation Information
    • 11.3.2 AstraZeneca Overview
    • 11.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 AstraZeneca Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 AstraZeneca Recent Developments
  • 11.4 Cipla
    • 11.4.1 Cipla Corporation Information
    • 11.4.2 Cipla Overview
    • 11.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Cipla Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Cipla Recent Developments
  • 11.5 Chiesi
    • 11.5.1 Chiesi Corporation Information
    • 11.5.2 Chiesi Overview
    • 11.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Chiesi Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Chiesi Recent Developments
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Corporation Information
    • 11.6.2 Boehringer Ingelheim Overview
    • 11.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Boehringer Ingelheim Recent Developments
  • 11.7 Aptar
    • 11.7.1 Aptar Corporation Information
    • 11.7.2 Aptar Overview
    • 11.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Aptar Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Aptar Recent Developments
  • 11.8 Novartis
    • 11.8.1 Novartis Corporation Information
    • 11.8.2 Novartis Overview
    • 11.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Novartis Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Novartis Recent Developments
  • 11.9 Philips Respironics
    • 11.9.1 Philips Respironics Corporation Information
    • 11.9.2 Philips Respironics Overview
    • 11.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Philips Respironics Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Philips Respironics Recent Developments
  • 11.10 Omron Healthcare
    • 11.10.1 Omron Healthcare Corporation Information
    • 11.10.2 Omron Healthcare Overview
    • 11.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Omron Healthcare Recent Developments
  • 11.11 PARI
    • 11.11.1 PARI Corporation Information
    • 11.11.2 PARI Overview
    • 11.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 PARI Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 PARI Recent Developments
  • 11.12 Skyepharma
    • 11.12.1 Skyepharma Corporation Information
    • 11.12.2 Skyepharma Overview
    • 11.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Skyepharma Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Skyepharma Recent Developments
  • 11.13 CareFusion
    • 11.13.1 CareFusion Corporation Information
    • 11.13.2 CareFusion Overview
    • 11.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 CareFusion Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 CareFusion Recent Developments
  • 11.14 Shanghai Huarui
    • 11.14.1 Shanghai Huarui Corporation Information
    • 11.14.2 Shanghai Huarui Overview
    • 11.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Shanghai Huarui Recent Developments
  • 11.15 Taian Character
    • 11.15.1 Taian Character Corporation Information
    • 11.15.2 Taian Character Overview
    • 11.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.15.4 Taian Character Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Taian Character Recent Developments
  • 11.16 Chia Tai Tianqing
    • 11.16.1 Chia Tai Tianqing Corporation Information
    • 11.16.2 Chia Tai Tianqing Overview
    • 11.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.16.5 Chia Tai Tianqing Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Pulmonary Drug Delivery Systems Industry Chain Analysis
  • 12.2 Pulmonary Drug Delivery Systems Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Pulmonary Drug Delivery Systems Production Mode & Process
  • 12.4 Pulmonary Drug Delivery Systems Sales and Marketing
    • 12.4.1 Pulmonary Drug Delivery Systems Sales Channels
    • 12.4.2 Pulmonary Drug Delivery Systems Distributors
  • 12.5 Pulmonary Drug Delivery Systems Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Pulmonary Drug Delivery Systems Industry Trends
  • 13.2 Pulmonary Drug Delivery Systems Market Drivers
  • 13.3 Pulmonary Drug Delivery Systems Market Challenges
  • 13.4 Pulmonary Drug Delivery Systems Market Restraints

14 Key Findings in The Global Pulmonary Drug Delivery Systems Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer